Azacitidine (BluePoint Laboratories)
Welcome to the PulseAid listing for the Azacitidine drug offered from BluePoint Laboratories. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
NON-PROPRIETARY NAME: | Azacitidine |
SUBSTANCE NAME: | AZACITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-07-01 |
END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Azacitidine from BluePoint Laboratories |
LABELER NAME: | BluePoint Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2017-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68001-313_5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a |
PRODUCT NDC: | 68001-313 |
APPLICATION NUMBER: | NDA208216 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers: